Skip to content
Subscriber Only
Business
Prognosis

Moderna Seeks Full FDA Approval for Its Covid-19 Vaccine

  • Shot was first cleared in U.S. on emergency basis last year
  • Application follows similar filing by rival Pfizer last month
Video player cover image
Moderna Says Vaccine Effective for 12-17 Year Olds in Study
Updated on

Moderna Inc. said it is seeking a full approval for its Covid-19 vaccine, a move that could make a shot cleared on an emergency basis during the pandemic into a stable source of revenue for years to come.

The company said in a statement Tuesday that it will submit data to the Food and Drug Administration on a rolling basis in coming weeks to support the application for use of the vaccine in people 18 and older.